Grethe Bergseth

1.6k total citations
28 papers, 1.3k citations indexed

About

Grethe Bergseth is a scholar working on Hematology, Immunology and Surgery. According to data from OpenAlex, Grethe Bergseth has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 15 papers in Immunology and 6 papers in Surgery. Recurrent topics in Grethe Bergseth's work include Complement system in diseases (14 papers), Platelet Disorders and Treatments (9 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Grethe Bergseth is often cited by papers focused on Complement system in diseases (14 papers), Platelet Disorders and Treatments (9 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Grethe Bergseth collaborates with scholars based in Norway, United States and Sweden. Grethe Bergseth's co-authors include Tom Eirik Mollnes, Knut Tore Lappegård, John D. Lambris, Vibeke Videm, Dorte Christiansen, Peter Garred, Michael Fung, Ole‐Lars Brekke, Tom E. Mollnes and Hilde Fure and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Annals of Thoracic Surgery.

In The Last Decade

Grethe Bergseth

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grethe Bergseth Norway 16 759 386 155 154 154 28 1.3k
Éric Wagner Canada 19 790 1.0× 344 0.9× 174 1.1× 267 1.7× 159 1.0× 45 1.5k
Yaseelan Palarasah Denmark 23 678 0.9× 231 0.6× 294 1.9× 90 0.6× 190 1.2× 79 1.4k
Paola Magotti United States 17 1.1k 1.4× 426 1.1× 395 2.5× 141 0.9× 172 1.1× 21 1.8k
Hilde Fure Norway 20 661 0.9× 235 0.6× 223 1.4× 117 0.8× 46 0.3× 38 1.2k
Kristina Nilsson‐Ekdahl Sweden 14 653 0.9× 251 0.7× 336 2.2× 365 2.4× 94 0.6× 24 1.5k
Masao Hagihara Japan 20 676 0.9× 317 0.8× 242 1.6× 148 1.0× 21 0.1× 131 1.4k
Daniela Longoni Italy 22 782 1.0× 519 1.3× 362 2.3× 85 0.6× 61 0.4× 43 1.5k
Troy D. Jaskowski United States 24 264 0.3× 200 0.5× 215 1.4× 139 0.9× 56 0.4× 54 1.3k
Masami Takei Japan 22 590 0.8× 214 0.6× 345 2.2× 87 0.6× 26 0.2× 141 1.8k
Yuichi Hasegawa Japan 22 322 0.4× 453 1.2× 392 2.5× 135 0.9× 33 0.2× 132 1.7k

Countries citing papers authored by Grethe Bergseth

Since Specialization
Citations

This map shows the geographic impact of Grethe Bergseth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grethe Bergseth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grethe Bergseth more than expected).

Fields of papers citing papers by Grethe Bergseth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grethe Bergseth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grethe Bergseth. The network helps show where Grethe Bergseth may publish in the future.

Co-authorship network of co-authors of Grethe Bergseth

This figure shows the co-authorship network connecting the top 25 collaborators of Grethe Bergseth. A scholar is included among the top collaborators of Grethe Bergseth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grethe Bergseth. Grethe Bergseth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lau, Corinna, Grethe Bergseth, Algirdas Grevys, et al.. (2019). NHDL, a recombinant V L /V H hybrid antibody control for IgG2/4 antibodies. mAbs. 12(1). 1686319–1686319. 3 indexed citations
2.
Christiansen, Dorte, Grethe Bergseth, Ole‐Lars Brekke, et al.. (2018). Granulocyte and monocyte CD11b expression during plasma separation is dependent on complement factor 5 (C5) – an ex vivo study with blood from a C5‐deficient individual. Apmis. 126(4). 342–352. 1 indexed citations
3.
Hellerud, Bernt Christian, Knut Dybwik, Søren Erik Pischke, et al.. (2017). Combined inhibition of C5 and CD14 efficiently attenuated the inflammatory response in a porcine model of meningococcal sepsis. Journal of Intensive Care. 5(1). 21–21. 19 indexed citations
4.
Skattum, Lillemor, Grethe Bergseth, Bjørg Lorentzen, et al.. (2017). Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome. Medicine. 96(11). e6338–e6338. 43 indexed citations
5.
Bergseth, Grethe, Per H. Nilsson, Elena B. Volokhina, et al.. (2017). Neoepitope based assays to detect C5a – Pitfalls and interpretations. Molecular Immunology. 89. 201–201. 1 indexed citations
6.
Nilsson, Per H., Grethe Bergseth, Elena B. Volokhina, et al.. (2017). Eculizumab-C5 complexes express a C5a neoepitope in vivo: Consequences for interpretation of patient complement analyses. Molecular Immunology. 89. 111–114. 10 indexed citations
7.
Bergseth, Grethe, Elena B. Volokhina, Lambertus P. van den Heuvel, et al.. (2016). Eculizumab treatment in pregnancy complicated with APS – Effects on mother and infant. Immunobiology. 221(10). 1193–1193. 1 indexed citations
8.
Volokhina, Elena B., Nicole C. A. J. van de Kar, Grethe Bergseth, et al.. (2015). Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome. Clinical Immunology. 160(2). 237–243. 43 indexed citations
9.
Bergseth, Grethe, Stian Foss, Tobias Gedde‐Dahl, et al.. (2014). Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn. Immunobiology. 220(4). 452–459. 86 indexed citations
10.
Bergseth, Grethe, Judith Krey Ludviksen, Michael Kirschfink, et al.. (2013). An international serum standard for application in assays to detect human complement activation products. Molecular Immunology. 56(3). 232–239. 152 indexed citations
11.
Vuuren, Bettine Jansen van, Grethe Bergseth, Tom Eirik Mollnes, & Andrew M. Shaw. (2013). Electroluminescent TCC, C3dg and fB/Bb epitope assays for profiling Complement cascade activation in vitro using an activated Complement serum calibration standard. Journal of Immunological Methods. 402(1-2). 50–56. 7 indexed citations
12.
Bergseth, Grethe, John D. Lambris, Tom Eirik Mollnes, & Knut Tore Lappegård. (2011). Artificial Surface-Induced Inflammation Relies on Complement Factor 5: Proof From a Deficient Person. The Annals of Thoracic Surgery. 91(2). 527–533. 18 indexed citations
13.
Brekke, Ole‐Lars, Bernt Christian Hellerud, Dorte Christiansen, et al.. (2011). Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood. Molecular Immunology. 48(15-16). 2159–2169. 23 indexed citations
14.
Lappegård, Knut Tore, Grethe Bergseth, Johan Riesenfeld, et al.. (2007). The artificial surface‐induced whole blood inflammatory reaction revealed by increases in a series of chemokines and growth factors is largely complement dependent. Journal of Biomedical Materials Research Part A. 87A(1). 129–135. 38 indexed citations
15.
Lappegård, Knut Tore, Johan Riesenfeld, Ole‐Lars Brekke, et al.. (2005). Differential Effect of Heparin Coating and Complement Inhibition on Artificial Surface-Induced Eicosanoid Production. The Annals of Thoracic Surgery. 79(3). 917–923. 25 indexed citations
16.
Lappegård, Knut Tore, Grethe Bergseth, Johan Riesenfeld, Joe Sexton, & Tom Eirik Mollnes. (2005). Role of granulocytes and monocytes in the polyvinyl chloride‐induced synthesis of interleukin 8, monocyte chemoattractant protein 1, and leukotriene B4. Journal of Biomedical Materials Research Part A. 74A(2). 230–236. 6 indexed citations
17.
Lappegård, Knut Tore, Michael Fung, Grethe Bergseth, et al.. (2004). Effect of complement inhibition and heparin coating on artificial surface–induced leukocyte and platelet activation. The Annals of Thoracic Surgery. 77(3). 932–941. 58 indexed citations
18.
Lappegård, Knut Tore, Michael Fung, Grethe Bergseth, Johan Riesenfeld, & Tom Eirik Mollnes. (2004). Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition. The Annals of Thoracic Surgery. 78(1). 38–44. 35 indexed citations
19.
Bergseth, Grethe, Knut Tore Lappegård, Vibeke Videm, & Tom Eirik Mollnes. (2000). A Novel Enzyme Immunoassay for Plasma Thrombospondin. Thrombosis Research. 99(1). 41–50. 34 indexed citations
20.
Videm, Vibeke, Dorte Christiansen, Grethe Bergseth, et al.. (1999). Platelet Compatibility of an Artificial Surface Modified with Functionally Active Heparin. Thrombosis and Haemostasis. 82(9). 1132–1136. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026